Intravenous administration of human umbilical cord blood-derived AC133+ endothelial progenitor cells in rat stroke model reduces infarct volume: Magnetic resonance imaging and histological findings

Asm Iskander, Robert A. Knight, Zheng Gang Zhang, James R. Ewing, Adarsh Shankar, Nadimpalli Ravi S. Varma, Hassan Bagher-Ebadian, Meser M. Ali, Ali S. Arbab, Branislava Janic

Research output: Contribution to journalArticle

37 Citations (Scopus)

Abstract

Endothelial progenitor cells (EPCs) hold enormous therapeutic potential for ischemic vascular diseases. Previous studies have indicated that stem/progenitor cells derived from human umbilical cord blood (hUCB) improve functional recovery in stroke models. Here, we examined the effect of hUCB AC133+ EPCs on stroke development and resolution in a middle cerebral artery occlusion (MCAo) rat model. Since the success of cell therapies strongly depends on the ability to monitor in vivo the migration of transplanted cells, we also assessed the capacity of magnetic resonance imaging (MRI) to track in vivo the magnetically labeled cells that were administered. Animals were subjected to transient MCAo and 24 hours later injected intravenously with 107 hUCB AC133EPCs. MRI performed at days 1, 7, and 14 after the insult showed accumulation of transplanted cells in stroke-affected hemispheres and revealed that stroke volume decreased at a significantly higher rate in cell-treated animals. Immunohistochemistry analysis of brain tissues localized the administered cells in the stroke-affected hemispheres only and indicated that these cells may have significantly affected the magnitude of endogenous proliferation, angiogenesis, and neurogenesis. We conclude that transplanted cells selectively migrated to the ischemic brain parenchyma, where they exerted a therapeutic effect on the extent of tissue damage, regeneration, and time course of stroke resolution.

Original languageEnglish (US)
Pages (from-to)703-714
Number of pages12
JournalStem Cells Translational Medicine
Volume2
Issue number9
DOIs
StatePublished - 2013

Fingerprint

Fetal Blood
Intravenous Administration
Stroke
Magnetic Resonance Imaging
Middle Cerebral Artery Infarction
Stem Cells
Neurogenesis
Brain
Therapeutic Uses
Cell- and Tissue-Based Therapy
Vascular Diseases
Stroke Volume
Cell Movement
Endothelial Progenitor Cells
Regeneration
Immunohistochemistry

Keywords

  • Angiogenesis
  • Brain ischemia
  • Stem/progenitor cell
  • Tissue regeneration
  • Umbilical cord blood

ASJC Scopus subject areas

  • Developmental Biology
  • Cell Biology

Cite this

Intravenous administration of human umbilical cord blood-derived AC133+ endothelial progenitor cells in rat stroke model reduces infarct volume : Magnetic resonance imaging and histological findings. / Iskander, Asm; Knight, Robert A.; Zhang, Zheng Gang; Ewing, James R.; Shankar, Adarsh; Varma, Nadimpalli Ravi S.; Bagher-Ebadian, Hassan; Ali, Meser M.; Arbab, Ali S.; Janic, Branislava.

In: Stem Cells Translational Medicine, Vol. 2, No. 9, 2013, p. 703-714.

Research output: Contribution to journalArticle

Iskander, Asm ; Knight, Robert A. ; Zhang, Zheng Gang ; Ewing, James R. ; Shankar, Adarsh ; Varma, Nadimpalli Ravi S. ; Bagher-Ebadian, Hassan ; Ali, Meser M. ; Arbab, Ali S. ; Janic, Branislava. / Intravenous administration of human umbilical cord blood-derived AC133+ endothelial progenitor cells in rat stroke model reduces infarct volume : Magnetic resonance imaging and histological findings. In: Stem Cells Translational Medicine. 2013 ; Vol. 2, No. 9. pp. 703-714.
@article{e844658b39864ee2a5bf925c90cd16f4,
title = "Intravenous administration of human umbilical cord blood-derived AC133+ endothelial progenitor cells in rat stroke model reduces infarct volume: Magnetic resonance imaging and histological findings",
abstract = "Endothelial progenitor cells (EPCs) hold enormous therapeutic potential for ischemic vascular diseases. Previous studies have indicated that stem/progenitor cells derived from human umbilical cord blood (hUCB) improve functional recovery in stroke models. Here, we examined the effect of hUCB AC133+ EPCs on stroke development and resolution in a middle cerebral artery occlusion (MCAo) rat model. Since the success of cell therapies strongly depends on the ability to monitor in vivo the migration of transplanted cells, we also assessed the capacity of magnetic resonance imaging (MRI) to track in vivo the magnetically labeled cells that were administered. Animals were subjected to transient MCAo and 24 hours later injected intravenously with 107 hUCB AC133EPCs. MRI performed at days 1, 7, and 14 after the insult showed accumulation of transplanted cells in stroke-affected hemispheres and revealed that stroke volume decreased at a significantly higher rate in cell-treated animals. Immunohistochemistry analysis of brain tissues localized the administered cells in the stroke-affected hemispheres only and indicated that these cells may have significantly affected the magnitude of endogenous proliferation, angiogenesis, and neurogenesis. We conclude that transplanted cells selectively migrated to the ischemic brain parenchyma, where they exerted a therapeutic effect on the extent of tissue damage, regeneration, and time course of stroke resolution.",
keywords = "Angiogenesis, Brain ischemia, Stem/progenitor cell, Tissue regeneration, Umbilical cord blood",
author = "Asm Iskander and Knight, {Robert A.} and Zhang, {Zheng Gang} and Ewing, {James R.} and Adarsh Shankar and Varma, {Nadimpalli Ravi S.} and Hassan Bagher-Ebadian and Ali, {Meser M.} and Arbab, {Ali S.} and Branislava Janic",
year = "2013",
doi = "10.5966/sctm.2013-0066",
language = "English (US)",
volume = "2",
pages = "703--714",
journal = "Stem cells translational medicine",
issn = "2157-6564",
publisher = "AlphaMed Press",
number = "9",

}

TY - JOUR

T1 - Intravenous administration of human umbilical cord blood-derived AC133+ endothelial progenitor cells in rat stroke model reduces infarct volume

T2 - Magnetic resonance imaging and histological findings

AU - Iskander, Asm

AU - Knight, Robert A.

AU - Zhang, Zheng Gang

AU - Ewing, James R.

AU - Shankar, Adarsh

AU - Varma, Nadimpalli Ravi S.

AU - Bagher-Ebadian, Hassan

AU - Ali, Meser M.

AU - Arbab, Ali S.

AU - Janic, Branislava

PY - 2013

Y1 - 2013

N2 - Endothelial progenitor cells (EPCs) hold enormous therapeutic potential for ischemic vascular diseases. Previous studies have indicated that stem/progenitor cells derived from human umbilical cord blood (hUCB) improve functional recovery in stroke models. Here, we examined the effect of hUCB AC133+ EPCs on stroke development and resolution in a middle cerebral artery occlusion (MCAo) rat model. Since the success of cell therapies strongly depends on the ability to monitor in vivo the migration of transplanted cells, we also assessed the capacity of magnetic resonance imaging (MRI) to track in vivo the magnetically labeled cells that were administered. Animals were subjected to transient MCAo and 24 hours later injected intravenously with 107 hUCB AC133EPCs. MRI performed at days 1, 7, and 14 after the insult showed accumulation of transplanted cells in stroke-affected hemispheres and revealed that stroke volume decreased at a significantly higher rate in cell-treated animals. Immunohistochemistry analysis of brain tissues localized the administered cells in the stroke-affected hemispheres only and indicated that these cells may have significantly affected the magnitude of endogenous proliferation, angiogenesis, and neurogenesis. We conclude that transplanted cells selectively migrated to the ischemic brain parenchyma, where they exerted a therapeutic effect on the extent of tissue damage, regeneration, and time course of stroke resolution.

AB - Endothelial progenitor cells (EPCs) hold enormous therapeutic potential for ischemic vascular diseases. Previous studies have indicated that stem/progenitor cells derived from human umbilical cord blood (hUCB) improve functional recovery in stroke models. Here, we examined the effect of hUCB AC133+ EPCs on stroke development and resolution in a middle cerebral artery occlusion (MCAo) rat model. Since the success of cell therapies strongly depends on the ability to monitor in vivo the migration of transplanted cells, we also assessed the capacity of magnetic resonance imaging (MRI) to track in vivo the magnetically labeled cells that were administered. Animals were subjected to transient MCAo and 24 hours later injected intravenously with 107 hUCB AC133EPCs. MRI performed at days 1, 7, and 14 after the insult showed accumulation of transplanted cells in stroke-affected hemispheres and revealed that stroke volume decreased at a significantly higher rate in cell-treated animals. Immunohistochemistry analysis of brain tissues localized the administered cells in the stroke-affected hemispheres only and indicated that these cells may have significantly affected the magnitude of endogenous proliferation, angiogenesis, and neurogenesis. We conclude that transplanted cells selectively migrated to the ischemic brain parenchyma, where they exerted a therapeutic effect on the extent of tissue damage, regeneration, and time course of stroke resolution.

KW - Angiogenesis

KW - Brain ischemia

KW - Stem/progenitor cell

KW - Tissue regeneration

KW - Umbilical cord blood

UR - http://www.scopus.com/inward/record.url?scp=84883314949&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84883314949&partnerID=8YFLogxK

U2 - 10.5966/sctm.2013-0066

DO - 10.5966/sctm.2013-0066

M3 - Article

C2 - 23934909

AN - SCOPUS:84883314949

VL - 2

SP - 703

EP - 714

JO - Stem cells translational medicine

JF - Stem cells translational medicine

SN - 2157-6564

IS - 9

ER -